AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 173 filers reported holding AERIE PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 0.35 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $614,000 | +27.1% | 40,600 | +103.0% | 0.02% | -64.3% |
| Q4 2019 | $483,000 | +100.4% | 20,000 | +59.4% | 0.04% | +90.9% |
| Q3 2019 | $241,000 | -21.8% | 12,549 | +151.0% | 0.02% | -26.7% |
| Q3 2018 | $308,000 | -26.5% | 5,000 | -37.2% | 0.03% | -65.5% |
| Q2 2017 | $419,000 | – | 7,965 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 906,317 | $16,078,000 | 4.88% |
| Asymmetry Capital Management, L.P. | 85,834 | $1,523,000 | 3.39% |
| March Altus Capital Management LP | 30,962 | $549,000 | 3.23% |
| DAFNA Capital Management LLC | 165,669 | $2,939,000 | 2.92% |
| Partner Investment Management, L.P. | 49,726 | $882,000 | 1.33% |
| Boulegeris Investments, Inc. | 93,320 | $1,655,000 | 1.27% |
| PFM Health Sciences, LP | 2,218,198 | $39,351,000 | 1.11% |
| NORTHPOINTE CAPITAL LLC | 443,125 | $7,861,000 | 1.02% |
| HARVEY CAPITAL MANAGEMENT INC | 121,850 | $2,161,000 | 0.86% |
| Granite Point Capital Management, L.P. | 70,000 | $1,242,000 | 0.85% |